Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Mesothelioma Applied Research Foundation
Другие языки:

    Mesothelioma Applied Research Foundation

    Подписчиков: 0, рейтинг: 0
    Mesothelioma Applied Research Foundation
    Formation 1999
    Type NPO
    Legal status Foundation
    Headquarters United States Washington, D.C.
    Location
    • 1615 L Street NW
      Suite 430
      Washington, D.C. 20036
      877.363.6376
      571.363.2784 (fax)
    Region served
    United States
    Executive Director
    Julie Powers
    Director of Communications and Operations
    Maja Belamaric
    Website Mesothelioma Applied Research Foundation

    The Mesothelioma Applied Research Foundation (Meso Foundation, formerly MARF) is a nonprofit organization funded by charitable donations that in turn funds mesothelioma research, provides support services to patients, educates the public, and advocates in Washington, DC for governmental funding for mesothelioma research. The organization's mission is to eradicate mesothelioma, a cancer caused by exposure to asbestos, as a life-ending disease.

    Mesothelioma.PNG

    Of its donors, 65% are individuals personally affected by mesothelioma. The remaining 35% include pharmaceutical companies, labor unions, plaintiff and defendant attorneys, and companies that have manufactured asbestos products.

    To date, the foundation has funded over $11.1 million in clinical research and is the host of the annual International Symposium on Malignant Mesothelioma. The organization was founded in 1999 and became tax-exempt in 2000. The organization's board of directors is composed by Marjorie G. Zauderer, MD, Memorial Sloan Kettering Cancer Center, Chair; Jessica Blackford-Cleeton; Cheryl Bruner, Esq.; Keith Cengel, MD, PhD, University of Pennsylvania; Patrick Forde, MD, Johns Hopkins University; Jason Foster, MD, University of Nebraska; Aaron Mansfield, MD, Mayo Clinic; Sanjay Popat, MD, PhD, The Royal Marsden; R. Taylor Ripley, MD, Baylor University; Buerkley Opalecky, MSN, RN, University of Chicago; Boris Sepesi, MD, MD Anderson Cancer Center; Daniel Sterman, MD, New York University; James Stevenson, MD, Cleveland Clinic; Antoinette Wozniak, MD, University of Pittsburgh; Bill Ziegler.

    See also

    External links



    Новое сообщение